查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1631164

外用药物市场规模、份额、趋势分析报告：依给药途径、类型、最终用途、地区、细分预测，2025-2030 年

Topical Drugs Market Size, Share & Trends Analysis Report By Route Of Administration (Dermal, Ophthalmic, Rectal, Vaginal, Nasal), By Type (Semi-solid, Transdermal), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

外用药物市场的成长与趋势

根据 Grand View Research Inc. 的一份新报告，到 2030 年全球外用药物市场规模预计将达到 2,693 亿美元。

预计 2025 年至 2030 年间，该产业的复合年增长率为 6.0%。推动该产业成长的关键因素包括皮肤病发病率的上升以及主要企业之间的策略联盟。预计预测期内，干癣、异位性皮肤炎和湿疹等皮肤感染疾病盛行率不断上升，加上对眼耳治疗的需求不断增长，将推动对经皮或经皮药物的需求。例如，2021年10月，艾伯维公司（AbbVie Inc.）获得FDA核准，推出用于治疗老花眼的盐酸毛果芸香碱滴眼液Vuity。

此外，根据 NCBI 的数据，干癣在欧洲的盛行率约为 1.92%，在北美的盛行率约为 1.5%。治疗皮肤病的外用药物的推出预计也将推动皮肤病药物的需求。例如，2020年9月，加拿大博士伦医疗公司针对干癣患者推出了一种新型抗干癣药物DuoBry Lotion。预计技术进步以及爱尔康公司和诺华公司等主要企业之间活性化的併购活动将推动该行业成长。例如，2022年6月，诺华公司收购了Kedalion Therapeutics，从而获得了AcuStream技术，该技术有助于实现眼科药物的精准经皮给药。

此外，2022 年 5 月，Alcon Inc. 从 Kala Pharmaceuticals, Inc. 收购了局部眼科药物 Eysuvis（洛替泼诺依碳酸酯混悬液），将其添加到其现有的干眼症治疗产品组合中。例如，根据世界卫生组织的数据，全球每年约有 1,100 万人发生烧伤，其中约 18 万人死亡。多种外用药物可用于治疗烧烫伤，包括磺胺嘧啶银霜、铋浸渍凡士林纱布、硝酸铈、醋酸磺胺米隆和结晶银。

外用药物市场报告重点

  • 药物输送将占据市场主导地位，到 2024 年将占 54.1% 的份额。
  • 半固态剂型凭藉其多功能性、易用性以及将活性成分直接输送到皮肤的有效性，在 2024 年占据了 61.9% 的收入份额，占据了市场主导地位。
  • 2024 年医院和诊所的收入份额最大，为 38.9%。这是因为需要专门干预的皮肤病和慢性病的发生率不断上升。
  • 2024 年，北美外用药物市场在全球市场占据主导地位，这得益于皮肤病的高发性、先进的医疗基础设施以及强劲的研发投入。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 外用药物市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析 – 波特五力分析
    • PESTLE分析

第 4 章外用药物市场：给药途径业务分析

  • 2024 年和 2030 年市场占有率
  • 给药途径细分仪表板
  • 2018 年至 2030 年按给药途径分類的市场规模、预测和趋势分析
  • 经经皮给药
  • 眼科药物输送
  • 直肠给药
  • 阴道给药
  • 鼻腔内给药

第 5 章局部用药市场：类型业务分析

  • 2024 年及 2030 年各类型市场占有率
  • 类型细分仪表板
  • 2018 年至 2030 年按类型分類的市场规模、预测与趋势分析
  • 半固态製剂
  • 液体製剂
  • 固态製剂
  • 经皮产品

第六章外用药物市场：最终用途业务分析

  • 2024 年及 2030 年终端用途市场占有率
  • 最终用途细分仪表板
  • 2018 年至 2030 年按最终用途分類的市场规模、预测和趋势分析
  • 居家医疗
  • 医院和诊所
  • 烧烫伤中心
  • 其他设施

第 7 章：外用药物市场：区域、估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 按国家/地区，2018 年至 2030 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区，2018 年至 2030 年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 按国家/地区，2018 年至 2030 年
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区，2018 年至 2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Bayer AG
    • Cipla
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • Novartis AG
    • Bausch Health Companies Inc.
    • Hisamitsu Pharmaceuticals Co., Inc.
    • Merck KGaA
    • GLENMARK PHARMACEUTICALS LTD.
    • MedPharm Ltd.
Product Code: GVR-4-68039-959-4

Topical Drugs Market Growth & Trends:

The global topical drugs market size is expected to reach USD 269.3 billion by 2030, according to a new report by Grand View Research Inc. The industry is expected to grow at a CAGR of 6.0% from 2025 to 2030. The key factors contributing to the industry growth include the increased prevalence of skin disorders coupled with strategic collaborations between key players. The increasing prevalence of skin infections, such as psoriasis, atopic dermatitis, and eczema, coupled with the rising demand for eye and ear therapies is expected to drive the demand for transdermal or dermal medicines during the forecast period. For instance, in October 2021, AbbVie Inc. received FDA approval for Vuity, a pilocarpine HCl ophthalmic solution for treating presbyopia.

In addition, according to the NCBI, the prevalence of psoriasis is nearly 1.92% and 1.5% among European and North American populations. The launch of topical medicines to treat skin diseases is also anticipated to propel the demand for dermal drugs. For instance, in September 2020, Bausch Health, Canada launched a novel antipsoriatic agent, Duobrii lotion for psoriasis patients.Advancements in technology and increased acquisitions and mergers activities among key players, such as Alcon, Inc. and Novartis AG, are anticipated to boost the industry's growth. For instance, in June 2022, Novartis AG acquired Kedalion Therapeutics, thereby acquiring AcuStream technology to facilitate accurate dermal delivery of ophthalmic medicines.

Moreover, in May 2022, Alcon Inc. acquired Eysuvis (loteprednol etabonate suspension) for topical ophthalmic use from Kala Pharmaceuticals, Inc., thereby adding to its existing portfolio of dry eye drugs.A high incidence of burn injuries is expected to render high utilization of topical medicines in treating burn injuries. For instance, according to the WHO, an estimated 11 million burn injuries occur annually worldwide, out of which about 180,000 cases are fatal. Various topical agents are used in treating burn injuries including silver sulfadiazine cream, bismuth-impregnated petroleum gauze, cerium nitrate, mafenide acetate, and nanocrystalline silver among others.

Topical Drugs Market Report Highlights:

  • Dermal drug delivery dominated the market and accounted for a share of 54.1% in 2024, fueled by its capacity to offer targeted treatment, user-friendly application, and improved patient compliance.
  • Semi-solid formulations led the market with a revenue share of 61.9% in 2024 due to their versatility, ease of use, and effectiveness in delivering active ingredients directly to the skin.
  • Hospitals & clinics held the largest revenue share of 38.9% in 2024, driven by the growing prevalence of skin disorders and chronic diseases necessitating professional intervention.
  • North America topical drugs market dominated the global market in 2024, driven by a high prevalence of skin disorders, advanced healthcare infrastructure, and robust investments in research and development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Route of Administration
    • 1.2.2. Type
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Topical Drugs Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Topical Drugs Market: Route of Administration Business Analysis

  • 4.1. Route of Administration Market Share, 2024 & 2030
  • 4.2. Route of Administration Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 4.4. Dermal Drug Delivery
    • 4.4.1. Dermal Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.5. Ophthalmic Drug Delivery
    • 4.5.1. Ophthalmic Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.6. Rectal Drug Delivery
    • 4.6.1. Rectal Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.7. Vaginal Drug Delivery
    • 4.7.1. Vaginal Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.8. Nasal Drug Delivery
    • 4.8.1. Nasal Drug Delivery Market, 2018 - 2030 (USD Million)

Chapter 5. Topical Drugs Market: Type Business Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Semi-solid Formulations
    • 5.4.1. Semi-solid Formulations Market, 2018 - 2030 (USD Million)
    • 5.4.2. Creams
      • 5.4.2.1. Creams Market, 2018 - 2030 (USD Million)
    • 5.4.3. Ointments
      • 5.4.3.1. Ointments Market, 2018 - 2030 (USD Million)
    • 5.4.4. Lotions
      • 5.4.4.1. Lotions Market, 2018 - 2030 (USD Million)
    • 5.4.5. Gel
      • 5.4.5.1. Gel Market, 2018 - 2030 (USD Million)
    • 5.4.6. Pastes
      • 5.4.6.1. Pastes Market, 2018 - 2030 (USD Million)
  • 5.5. Liquid Formulations
    • 5.5.1. Liquid Formulations Market, 2018 - 2030 (USD Million)
    • 5.5.2. Suspensions
      • 5.5.2.1. Suspensions Market, 2018 - 2030 (USD Million)
    • 5.5.3. Solutions
      • 5.5.3.1. Solutions Market, 2018 - 2030 (USD Million)
  • 5.6. Solid Formulations
    • 5.6.1. Solid Formulations Market, 2018 - 2030 (USD Million)
    • 5.6.2. Powders
      • 5.6.2.1. Powders Market, 2018 - 2030 (USD Million)
    • 5.6.3. Suppositories
      • 5.6.3.1. Suppositories Market, 2018 - 2030 (USD Million)
  • 5.7. Transdermal Products
    • 5.7.1. Transdermal Products Market, 2018 - 2030 (USD Million)
    • 5.7.2. Transdermal Patches
      • 5.7.2.1. Transdermal Patches Market, 2018 - 2030 (USD Million)
    • 5.7.3. Transdermal Semi-Solids
      • 5.7.3.1. Transdermal Semi-Solids Market, 2018 - 2030 (USD Million)

Chapter 6. Topical Drugs Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Home Care Settings
    • 6.4.1. Home Care Settings Market, 2018 - 2030 (USD Million)
  • 6.5. Hospitals & Clinics
    • 6.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 6.6. Burn Centers
    • 6.6.1. Burn Centers Market, 2018 - 2030 (USD Million)
  • 6.7. Other Facilities
    • 6.7.1. Other Facilities Market, 2018 - 2030 (USD Million)

Chapter 7. Topical Drugs Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Bayer AG
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Cipla
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. GSK plc
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Johnson & Johnson Services, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Novartis AG
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Bausch Health Companies Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Hisamitsu Pharmaceuticals Co., Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Merck KGaA
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. GLENMARK PHARMACEUTICALS LTD.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. MedPharm Ltd.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global topical drugs market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 5 Global topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 6 Global topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 9 North America topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 10 North America topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 12 U.S. topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 15 Canada topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 16 Canada topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 18 Mexico topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 19 Mexico topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 22 Europe topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 23 Europe topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 25 UK topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 26 UK Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 28 Germany topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 29 Germany topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 31 France topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 32 France Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 34 Italy topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 35 Italy topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 37 Spain topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 38 Spain topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 40 Norway topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 41 Norway Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Denmark topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 43 Denmark topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 44 Denmark topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Sweden topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 46 Sweden topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 47 Sweden topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 53 Japan topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 54 Japan topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 56 China topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 57 China topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 59 India topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 60 India topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 62 Australia topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 63 Australia topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 64 South Korea topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 65 South Korea topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 66 South Korea topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Thailand topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 68 Thailand topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 69 Thailand topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 72 Latin America topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 73 Latin America topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 75 Brazil topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 76 Brazil topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Argentina topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 78 Argentina topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 79 Argentina topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 85 South Africa topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 86 South Africa topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 91 UAE topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 92 UAE topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 94 Kuwait topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait topical drugs market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Topical drugs market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Route of administration and type outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Topical drugs market dynamics
  • Fig. 13 Topical drugs market: Porter's five forces analysis
  • Fig. 14 Topical drugs market: PESTLE analysis
  • Fig. 15 Topical drugs market: Route of administration segment dashboard
  • Fig. 16 Topical drugs market: Route of administration market share analysis, 2024 & 2030
  • Fig. 17 Dermal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 18 Ophthalmic drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 19 Rectal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 20 Vaginal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 21 Nasal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 22 Topical drugs market: Type segment dashboard
  • Fig. 23 Topical drugs market: Type market share analysis, 2024 & 2030
  • Fig. 24 Semi-solid formulations market, 2018 - 2030 (USD Million)
  • Fig. 25 Creams market, 2018 - 2030 (USD Million)
  • Fig. 26 Ointments market, 2018 - 2030 (USD Million)
  • Fig. 27 Lotions market, 2018 - 2030 (USD Million)
  • Fig. 28 Gel market, 2018 - 2030 (USD Million)
  • Fig. 29 Pastes market, 2018 - 2030 (USD Million)
  • Fig. 30 Liquid formulations market, 2018 - 2030 (USD Million)
  • Fig. 31 Suspensions market, 2018 - 2030 (USD Million)
  • Fig. 32 Solutions market, 2018 - 2030 (USD Million)
  • Fig. 33 Solid formulations market, 2018 - 2030 (USD Million)
  • Fig. 34 Powders market, 2018 - 2030 (USD Million)
  • Fig. 35 Suppositories market, 2018 - 2030 (USD Million)
  • Fig. 36 Transdermal products market, 2018 - 2030 (USD Million)
  • Fig. 37 Transdermal patches market, 2018 - 2030 (USD Million)
  • Fig. 38 Transdermal semi-solids market, 2018 - 2030 (USD Million)
  • Fig. 39 Topical drugs market: End use segment dashboard
  • Fig. 40 Topical drugs market: End use market share analysis, 2024 & 2030
  • Fig. 41 Home care settings market, 2018 - 2030 (USD Million)
  • Fig. 42 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 43 Burn centers market, 2018 - 2030 (USD Million)
  • Fig. 44 Other facilities market, 2018 - 2030 (USD Million)
  • Fig. 45 Topical drugs market revenue, by region
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 Regional marketplace: Key takeaways
  • Fig. 48 North America topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 49 U.S. country dynamics
  • Fig. 50 U.S. topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 51 Canada country dynamics
  • Fig. 52 Canada topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico country dynamics
  • Fig. 54 Mexico topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 55 Europe topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 56 UK country dynamics
  • Fig. 57 UK topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 58 Germany country dynamics
  • Fig. 59 Germany topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 60 France country dynamics
  • Fig. 61 France topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 62 Italy country dynamics
  • Fig. 63 Italy topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 64 Spain country dynamics
  • Fig. 65 Spain topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 66 Norway country dynamics
  • Fig. 67 Norway topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 68 Sweden country dynamics
  • Fig. 69 Sweden topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 70 Denmark country dynamics
  • Fig. 71 Denmark topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 73 Japan country dynamics
  • Fig. 74 Japan topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 75 China country dynamics
  • Fig. 76 China topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 77 India country dynamics
  • Fig. 78 India topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 79 Australia country dynamics
  • Fig. 80 Australia topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea country dynamics
  • Fig. 82 South Korea topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 83 Thailand country dynamics
  • Fig. 84 Thailand topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 85 Latin America topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 86 Brazil country dynamics
  • Fig. 87 Brazil topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 88 Argentina country dynamics
  • Fig. 89 Argentina topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 90 MEA topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa country dynamics
  • Fig. 92 South Africa topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia country dynamics
  • Fig. 94 Saudi Arabia topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 95 UAE country dynamics
  • Fig. 96 UAE topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 97 Kuwait country dynamics
  • Fig. 98 Kuwait topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 99 Company categorization
  • Fig. 100 Company market position analysis
  • Fig. 101 Strategic framework